Target intelligence / Profile preview

EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2)

Target
EFEMP2
Molecular classification
Other (extracellular matrix protein), Fibulin family
01

Overview

EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2), also known as fibulin-4, is a member of the fibulin family of extracellular matrix proteins. EFEMP2 is essential for the assembly of elastic fibers, providing a scaffold that coordinates cross-linking of elastin by interacting with tropoelastin, lysyl oxidase, and fibrillin-1. It is critical for connective tissue integrity, especially in tissues rich in elastic fibers such as blood vessels, lungs, and skin. Loss-of-function mutations in EFEMP2 result in autosomal recessive cutis laxa type 1B (ARCL1B), which is characterized by loose skin, pulmonary emphysema, and severe cardiovascular defects, including aortic aneurysm. Its functions extend to collagen maturation and regulation of smooth muscle cell differentiation, underscoring its central role in extracellular matrix formation and vascular stability[1][2][3][4].

Other names
Fibulin-4FBLN4UPH1MBP1ARCL1BMutant p53 binding protein 1Fibulin 4
02

Biological functions

Elastic fiber assemblyConnective tissue homeostasisExtracellular matrix organizationCollagen fibril assemblySmooth muscle cell differentiation
03

Disease associations

Cutis laxa (autosomal recessive, type 1B)Cardiovascular disease (aortic aneurysm, arterial tortuosity, vascular defects)Skeletal abnormalitiesPulmonary emphysema
04

Safety considerations

Pathogenic mutations are associated with life-threatening connective tissue and vascular disorders such as aortic aneurysm and severe cardiovascular abnormalities[2][1][4].
05

Biomarkers

Fibulin-4 may serve as a biomarker for disorders of connective tissue integrity, especially cutis laxa and related vascular pathologies[2][1].

Beyond the preview

Go deeper on EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call